Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Medullary Thyroid Carcinoma - Biology - Management - Treatment (Paperback, Softcover reprint of the original 1st ed. 2015)
Loot Price: R4,659
Discovery Miles 46 590
|
|
Medullary Thyroid Carcinoma - Biology - Management - Treatment (Paperback, Softcover reprint of the original 1st ed. 2015)
Series: Recent Results in Cancer Research, 204
Expected to ship within 10 - 15 working days
|
This book offers a comprehensive overview of medullary thyroid
carcinoma, both in the more common sporadic form and in the
familial form, multiple endocrine neoplasia (MEN) types 2A and 2B.
The coverage includes, but is not limited to, molecular biology and
genetics, pathology, clinical presentation, imaging techniques,
surgical treatment, and follow-up. The role of calcitonin as a
highly sensitive and specific tumor marker for the screening,
diagnosis, and follow-up of MTC and metastatic disease is
described, and the significance of other tumor markers is also
considered. With regard to treatment, the use of thyroidectomy is
fully discussed, including in children carrying the mutations in
the RET proto-oncogene considered causative for MEN 2.
Additionally, the value of tyrosine kinase inhibitors as the most
effective treatment modality in patients with a large tumor burden
or rapid tumor growth, or both, is explained. Medullary Thyroid
Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal
source of up-to-date information for a wide range of practitioners,
including endocrinologists, oncologists, internal medicine
specialists, geneticists, and nuclear medicine physicians.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.